Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Equity earnings (loss) in AmerisourceBergen

Impairment of goodwill

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Walgreens

Duane Reade is a subsidiary of Walgreens Boots Alliance, is a chain of pharmacy and convenience stores, primarily located in New York City, known for its high volume small store layouts in densely populated Manhattan locations.

Duane Reade

Boots UK is a pharmacy chain in the United Kingdom, Ireland, Norway, Thailand and other territories. Boots became a subsidiary of the new company, Walgreens Boots Alliance, on 31 December 2014.

Boots UK

Alliance Healthcare was formerly Alliance UniChem, wholesales, distributes, and retails pharmaceutical, surgical, medical, and healthcare products throughout Europe. The company supplies more than 110,000 pharmacies, doctors, health centres and hospitals from over 288 distribution centres in 11 countries. The company is a wholly owned subsidiary of Walgreens Boots Alliance, which was formed by the merger of Walgreens with its former parent Alliance Boots in 2014. Alliance Boots had itself been formed in 2006 by the merger of Boots Group and Alliance UniChem on 31 July 2006. Alliance UniChem was rebranded Alliance Healthcare in 2009.

Alliance Healthcare

Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Walgreens reports Q1 earnings decline, eyes growth opportunities ahead

Walgreens faces challenges from COVID impacts and investments but is on track to achieve full-year guidance.
Strategic acquisitions and scaling U.S. Healthcare present opportunities for growth and profitability.
Despite first-half declines, the company anticipates improvements in margins and performance in the second half.
Efforts to optimize cash flow and investments position Walgreens for future growth and success.

Walgreens reports 4.5% sales growth in Q2 2023 earnings

Walgreens remains cautiously optimistic about managing potential changes in health plans and anticipates a strong second half of the year. The company is targeting debt reduction and small tuck-on acquisitions in healthcare as capital allocation priorities.

Walgreens (WBA) reports mixed Q3 performance, focuses on profitability

Walgreens (WBA) Q3 2023 earnings call highlights mixed performance with a focus on profitability enhancement.
Strategic partnerships, cost management programs, and capital allocation priorities support long-term value creation.
Challenges in margin pressures, script growth, and operational issues require immediate actions for profitability.
Opportunities lie in unlocking profitability, market developments, and demand for risk-based health care services.

Walgreens appoints new CEO to drive cost savings and script growth opportunities

Walgreens is strategically positioning itself for operational efficiency and cost savings in fiscal year 2024. The company's new CEO, Tim Wentworth, is expected to drive healthcare expertise and cost-effective outcomes. Despite challenges like lower contributions and segment declines, Walgreens is leveraging opportunities for script growth and financial improvement.

Walgreens Q1 Earnings: Navigating Challenges, Focused on Value Creation

Walgreens is navigating challenges in the pharmacy sector while focusing on strategic initiatives to drive value creation and sustainable growth. The company's emphasis on partnerships, cost-saving actions, and a shift towards value-based reimbursement models positions them for future success in the evolving healthcare landscape.

Walgreens reports solid Q2 results, focuses on growth strategies

Walgreens navigates retail challenges with strong operational performance. Focus on cost discipline, portfolio optimization, and cash flow improvement. Strategic decisions to drive growth and unlock value in healthcare areas.

Walgreens Q3 Earnings Miss Expectations Amid Challenges

Walgreens' Q3 2024 earnings call highlighted a challenging quarter with missed expectations, driven by pressures in the retail pharmacy sector and adverse market conditions. CEO Tim Wentworth emphasized ongoing strategic reviews and cost management initiatives as key to navigating these challenges. The company remains committed to transforming its business model to better serve customers and improve operational efficiency.

Walgreens (WBA) reports Q4 earnings, focuses on growth strategies

Walgreens (WBA) focused on financial stability, cost efficiency, and strategic growth initiatives in Q4 2024 earnings call.
The company aims to address challenges like disruptions, inflation, and underperforming stores while leveraging strengths in cash flow and cost-cutting.
Opportunities in store optimization, digital enhancement, and asset monetization are key areas for future growth.
Overall, Walgreens is navigating challenges, leveraging strengths, and pursuing opportunities to enhance financial performance and resilience.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Integrated healthcare and pharmacy retailer Walgreens Boots Alliance Inc. NYSE: WBA stock has fallen 21.75% year-to-date (YTD), hitting price levels not seen since 2010.

Time Warp: Walgreens Stock Travels Back in Time to 2010

As consumers struggle with high prices, Walgreens is working to woo its loyalty program members. The pharmacy chain on Monday (July 10) announced “myW Days,” a weeklong event — July 23-29 — for members of its myWalgreens program offering rewards and savings on all items in-store, online and on its app.

Walgreens Woos Cautious Consumers With 'MyW Days'

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens today announced a new weeklong shopping event, myW Days, which will take place July 23-29 for myWalgreens members. The event will offer unprecedented rewards and savings on all purchases in-store, online and in the Walgreens app. Since its launch in 2020, myWalgreens has become America's largest free-to-join health and wellness loyalty program. “We're launching myW Days to thank myWalgreens members and show how much we appreciate them,” said Linh Pete.

Walgreens Announces myW Days, an Exclusive Event Offering Deep Discounts and its Most Rewards Ever for myWalgreens Members Throughout the Week of July 23

CVS Health

CVS Health has increased revenue more consistently. Walgreens Boots Alliance's dividend yield is almost twice that of CVS.

Better Buy: CVS Health vs. Walgreens Boots Alliance

Dollar General

Verizon

The stock market had a tremendous start to 2023. It might leave investors wondering what cheap blue-chip stocks are left to buy at reasonable prices.

3 Cheap Blue-Chip Stocks to Buy Before They Bounce Back

Pharmacy businesses aren't intended to grow quickly. But they can sometimes grow consistently over time.

Could Walgreens Boots Alliance Stock Help You Become a Millionaire?

Johnson & Johnson

The great thing about strong, consistent dividend stocks? They tend to have strong, consistent businesses.

3 Beaten-Down Dividend Stocks Primed for a Profitable Comeback

Amgen

Cisco Systems

Chevron

Dow Inc

Coca-Cola

"The Dow if the company has an excellent reputation, demonstrates sustained growth, and is of interest to a large number of investors. Sector representation is also a consideration.”–DowJones&Co. The highest-yield 10 stocks are June's Dogs of the Dow: KO, CSCO, GS, AMGN, CVX, IBM, DOW, MMM, WBA, and VZ, averaged a 4.79% annual yield. Thirty Dow stocks represent nine of eleven sectors. Dow Jones tracks utilities as a separate index and omits real estate. Broker top-ten target-estimated July net-gains ranged 14.83%-30.2%, topped by DIS 7/5/23.

Buy 3 July Dogs Of The Dow, Watch 6

CrowdStrike

Wall Street has taken growth investors on a wild ride over the past two years. The predominantly growth-driven Nasdaq 100 is home to two amazing deals hiding in plain sight.

2 Nasdaq 100 Stocks That Are Surefire Buys in July and 1 to Avoid

Walgreens Boots Alliance Inc. ( WBA , Financial) has been embarking on a transformative journey for years now, leveraging innovation and strategic investments to improve customer experiences, optimize supply chains and expand into the primary care market.

Walgreens Boots Alliance Is Transforming Its Business for Growth

Carnival

Joby Aviation

Levi Strauss

Squarespace

With the stock market facing persistent macroeconomic challenges and the looming possibility of a US recession, investors find themselves in a precarious position, grappling with volatility and uncertainty.

5 stocks to avoid trading next week

Walgreens cut its guidance for the fiscal year due to lower COVID-19 demand. The company has found more opportunities for cost savings, bolstering its goals.

Are Walgreens Boots Alliance Investors Overreacting to the Company's Disappointing Earnings?

Realty Income Corp

As investors seek stable income streams and long-term growth opportunities, these three dividend-aristocrat stocks may be preferable. These companies have demonstrated their commitment to shareholders by consistently increasing dividends for years.

Snag Royal Returns: 3 Dividend Aristocrat Stocks to Buy in July

Stocks can have noticeably high yields due to a falling stock price or a growing dividend. An ability to support the dividend with free cash flow matters more than how high the yield is.

5 Dow Stocks Yield Over 5%, but Which Is the Best Buy Now?

American Electric Power Company

Gilead Sciences

Kraft Heinz

Likely, 2023 will be known as the year artificial intelligence became a permanent part of the investing lexicon.

Why the 5 Highest-Yielding Nasdaq Stocks Could Rip Higher With the Red-Hot Summer Rally

Cummins

Cintas Corp

Hershey

Mondelez

J. M. Smucker

Stanley Black & Decker

June ended with a bang from a dividend increase perspective. Now, it is time to make sure July delivers, too. Dividends are the foundation of our goal to reach financial freedom. We continuously invest in dividend growth stocks to grow our passive income. In 2023, with high inflation, bank runs and other major events, buying undervalued dividend stocks that increase your dividend is as crucial as ever.

7 Expected Dividend Increases In July 2023

Salesforce

UnitedHealth Group

Walgreens slashed its guidance as its pivot to healthcare continues to underwhelm. Salesforce is seeing growth slow even as it sees a new opportunity in AI.

Is It Time to Buy the Dow Jones' 3 Worst-Performing June Stocks?

We've also got a look at how to make the most out of dividend investing.

Walgreens Boots Alliance Surpised the Market, and Not in a Good Way

Walgreens Boots Alliance stock fell sharply after the company reported results that missed Wall Street's earnings expectations. The U.S. healthcare business Walgreens invested heavily in reported sales that more than tripled year over year, thanks to a recent acquisition.

Is Beaten-Down Walgreens Stock a Buy on the Dip?

Apple

Lordstown Motors

Here are some of the major companies whose stocks moved on the week's news.

The Score: Apple, Lordstown Motors, Walgreens and More Stocks That Defined the Week

Walgreens expects to close 150 locations in the United States and 300 locations in the United Kingdom, Walgreens Boots Alliance CFO James Kehoe said in the company's earnings call this week.

Walgreens is closing 450 locations

Advance Auto Parts

Enphase Energy

NVIDIA

Nvidia led the gains in both the Nasdaq 100 and the S&P 500. Salesforce led the Dow industrials.

The Stock Market's Biggest Winners and Losers for First Half of 2023

Devon Energy

Icahn Enterprises

Stocks that pay dividends can be great for investors. After all, who doesn't like to receive a regular payment from their investments?

3 Most Undervalued, High-Yield Stocks to Buy Now

Walgreens (WBA) will sponsor Children with Diabetes' FFL event to make a difference in the lives of the 122 million individuals afflicted by diabetes and pre-diabetes.

Walgreens (WBA) to Advance Diabetes Care at FFL Conference

Walgreens stock (NYSE: WBA) is down 11% in a week, underperforming the broader markets, with the S&P500 not seeing any change.

News for Walgreens Stock (WBA)